Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Cells. 2021 May 11;10(5):1164. doi: 10.3390/cells10051164.
The central role mitochondria play in cellular homeostasis has made its study critical to our understanding of various aspects of human health and disease. Mitochondria rely on the translocase of the outer membrane (TOM) complex for the bulk of mitochondrial protein import. In addition to its role as the major entry point for mitochondrial proteins, the TOM complex serves as an entry pathway for viral proteins. TOM complex subunits also participate in a host of interactions that have been studied extensively for their function in neurodegenerative diseases, cardiovascular diseases, innate immunity, cancer, metabolism, mitophagy and autophagy. Recent advances in our structural understanding of the TOM complex and the protein import machinery of the outer mitochondrial membrane have made structure-based therapeutics targeting outer mitochondrial membrane proteins during mitochondrial dysfunction an exciting prospect. Here, we describe advances in understanding the TOM complex, the interactome of the TOM complex subunits, the implications for the development of therapeutics, and our understanding of the structure/function relationship between components of the TOM complex and mitochondrial homeostasis.
线粒体在细胞稳态中起着核心作用,因此研究线粒体对于我们理解人类健康和疾病的各个方面至关重要。线粒体依赖外膜转位酶(TOM)复合物来完成大部分线粒体蛋白的输入。除了作为线粒体蛋白的主要进入点之外,TOM 复合物还是病毒蛋白的进入途径。TOM 复合物亚基还参与了许多相互作用,这些相互作用的功能在神经退行性疾病、心血管疾病、先天免疫、癌症、代谢、线粒体自噬和细胞自噬等方面得到了广泛研究。我们对 TOM 复合物和外线粒体膜蛋白导入机制的结构理解的最新进展,使得针对线粒体功能障碍期间外线粒体膜蛋白的基于结构的治疗成为一个令人兴奋的前景。在这里,我们描述了对 TOM 复合物、TOM 复合物亚基相互作用组、治疗意义以及我们对 TOM 复合物成分与线粒体稳态之间的结构/功能关系的理解方面的进展。